About the Company
The Center for Aquaculture Technologies was established in 2012, with focus on the use of advanced technologies to improve aquaculture productivity. The company is a wholly owned subsidiary of Linnaeus Capital Partners B.V, and maintains research operations in San Diego, CA and PEI, Canada.
Meet our team
Prior to helping launch CAT, Dr. Buchanan served for 5 years as the Director of Research and Development at AquaBounty Technologies. Previously, Dr. Buchanan has held a series of research leadership positions at Louisiana State University, the University of California at San Diego School of Medicine, and Kent SeaTech Corporation. Dr. Buchanan has led research on the application of genetic engineering to aquaculture, the use of selective breeding, hatchery technologies, and genomics for improved productivity in finfish, the development of novel therapeutics for aquaculture, and the molecular and genetic basis for virulence in aquatic and human pathogens. He also has experience directing and conducting studies compliant with governmental regulatory standards (GLP/GCP).
Dr. Debbie Plouffe, Executive Vice President of Research
Dr. Plouffe completed her undergraduate degree at the University of Alberta graduating first with a BSc. in Invertebrate Biology and later with a Ph.D. in Physiology and Cell Biology with a focus on comparative immunology and immunoparsitology. Dr. Plouffe is a molecular and cell biologist with a strong background in fish immunology and fish health gaining experience in this area through a research position held at the National Research Council in Halifax where she was involved in a project funded by the NRC-Genomics and Health Initiative to examine genomic approaches to disease management in Atlantic salmon. She has been leading research projects in the industry since 2007 and has been involved in several regulated studies, designed and implemented diagnostic assays, and participates in study design, execution, and data analysis.
From 2007-2012 she has served as the Group Leader for Research and Development for AquaBounty Canada on PEI where she was responsible for management of research programs in Canada in support of the development and optimization of growth hormone transgenic salmonids in a GLP/GMP environment. Currently she is responsible for the management of research priorities and development of new projects, contracts, and collaborations from the CATC facility on PEI.
Jason Stannard, Executive Vice President of Genotyping & Diagnostics
Jason Stannard devotes his efforts to overseeing company operations and managing various research projects focused on the development of diagnostics, therapeutics and genetic improvement technologies to enhance growth, health and disease resistance in aquatic species. Prior to joining CAT, Mr. Stannard served as Laboratory Director at AquaBounty Technologies (2005-2012) and Research Coordinator at Kent SeaTech (1999-2005); where he was responsible for managing laboratory and aquatics operations and leading a variety of R&D projects focused on developing improved diagnostics, genetics and animal health technologies for applications in aquaculture. Mr. Stannard has over twenty years of experience in operations and fisheries and aquaculture-based research.
Angela MacDonald, Corporate Controller
Angela has been with CATC since 2014. She graduated UPEI with her BBA and then went on to receive her MBA from St. Mary’s University. She also completed her CPA, CMA in 2014. Angela currently oversees accounting procedures in the US and Canadian offices to support senior management in both locations.
Dr. André Dumas earned his PhD in animal nutrition at the University of Guelph in 2008. Dr. Dumas served as Research scientist for a multinational feed company and Director of aquaculture at a research institute before joining CATC in June 2015. His area of scientific expertise relates to ingredient development, testing of specialty feed ingredients, feed formulation and processing, shadow pricing, mathematical modelling and nutrigenomics. His expertise encompasses warm and cold water species farmed in fresh or salt water. Dr. Dumas publishes articles for peer reviewed scientific journals and trade magazines. Dr. Dumas is committed to the success of CATC’s customers and strive to create value through innovation. He has deep aquaculture nutrition business acumen, disciplined managerial and leadership abilities, and well established network of trusting relationships with industry and academia.
Dr. Mark Braceland, Director of Fish Health
Dr. Mark Braceland joined CATC in January 2016 as a senior research scientist. Previously he obtained a PhD in animal health and worked as a post doc at the University of Glasgow. His expertise are primarily in the identification and assay development of novel markers of fish health generally and of disease associated pathology through proteomic and biochemical techniques. His work has led to a number of scientific articles and patents. At CATC he is part of the fish health team designing novel in vitro and in vivo models and efficacy markers for the development of technologies to improve the sustainability and growth of aquaculture.
Dr. Tiago S. Hori, Associate Director of Genomics
Dr. Tiago S. Hori is the Associated Director of Genomics at the Center for Aquaculture Technologies. Dr. Hori holds a B.Sc in Biology, a M.Sc in Genetics and Biochemistry and a Ph.D in Biology. Dr. Hori work focuses on understanding the architecture of traits relevant to the aquaculture industry. His research has included the use of both functional and structural genomics to investigated the molecular mechanisms driving such traits. Dr. Hori has extensive experience in the use of microarrays, RNA-seq, high and medium density genotyping and QPCR as well as the bioinformatic pipelines required to analyze genomic data. To date Dr. Hori has published over 25 scientific articles in high-impact peer reviewed journals such as BMC Genomics, Physiological Genomics, Aquaculture and Molecular Immunology.